Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

A1AT Genotyping Test

K-Number: K192858 · 2019-11-05

Decision Date2019-11-05
Product CodePZH
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

A1AT Genotyping Test is a medical device manufactured by Progenika Biopharma S.A., A Grifols Company. It received FDA 510(k) clearance on 2019-11-05 under approval number K192858. The device is classified under product code PZH. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the A1AT Genotyping Test?

A1AT Genotyping Test is a medical device that received FDA 510(k) clearance on 2019-11-05. It is manufactured by Progenika Biopharma S.A., A Grifols Company. The 510(k) number is K192858.

When was A1AT Genotyping Test approved by the FDA?

A1AT Genotyping Test received FDA 510(k) clearance on 2019-11-05, under approval number K192858.

What company makes A1AT Genotyping Test?

A1AT Genotyping Test is manufactured by Progenika Biopharma S.A., A Grifols Company.

What is the FDA product code for A1AT Genotyping Test?

The FDA product code for A1AT Genotyping Test is PZH.

Other Devices by Progenika Biopharma S.A., A Grifols Company

Related Devices (Code: PZH)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.